この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2002/12/51 分で読めます
New Animal Drugs; Tilmicosin
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for subcutaneous injection of tilmicosin phosphate solution for the treatment of ovine respiratory disease (ORD). FDA is also amending the regulations to add tolerances for residues of tilmicosin in sheep muscle and liver and in cattle muscle.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →